BioNTech says vaccine likely to be effective against India variant
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
FRIDAY, MAY 20, 2022
FRIDAY, MAY 20, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
BioNTech says vaccine likely to be effective against India variant

Coronavirus chronicle

Reuters
21 May, 2021, 12:25 pm
Last modified: 21 May, 2021, 03:00 pm

Related News

  • Pfizer/BioNTech Covid-19 vaccine shows 90.7% efficacy in trial in children
  • Pfizer/BioNTech Covid-19 vaccine effectiveness drops after 6 months, study shows
  • US FDA grants full approval to Pfizer-BioNTech Covid-19 vaccine
  • Pfizer, BioNtech submit data to FDA for Covid-19 vaccine booster authorisation
  • BioNTech says vaccine repeats beat devising new one for now

BioNTech says vaccine likely to be effective against India variant

The company said in a statement Chief Executive Ugur Sahin felt encouraged by recent findings in a scientific paper based on blood analysis of vaccinated individuals, which showed that the antibodies elicited by the vaccine were able to neutralise the Indian variant

Reuters
21 May, 2021, 12:25 pm
Last modified: 21 May, 2021, 03:00 pm
Ugur Sahin, CEO and co-founder of German biotech firm BioNTech. Picture: Reuters
Ugur Sahin, CEO and co-founder of German biotech firm BioNTech. Picture: Reuters

BioNTech SE said on Thursday the Covid-19 vaccine it developed with Pfizer should be roughly as effective against the new coronavirus variant first detected in India as it has been shown to be against the South African variant.

The company said in a statement Chief Executive Ugur Sahin felt encouraged by recent findings in a scientific paper based on blood analysis of vaccinated individuals, which showed that the antibodies elicited by the vaccine were able to neutralise the Indian variant.

Since the blood tests on the variant that was first detected in South Africa had shown similar results, promising real-world data on the vaccine's effectiveness against the South African variant of about 75% led him to believe that its actual effectiveness against the Indian variant "might be in the same range".

"So far we've had the chance to test our vaccine against more than 30 variants of the virus. It has proven effective against mutations so far," Sahin said earlier, speaking on Turkish television.

Sahin, a German scientist with Turkish parents, spoke in Turkish after virtually attending the Turkish government's science council meeting.

"We expect (our vaccine) to protect against infections by 70% to 75%," he said on TV, in what the company later said was in reference to the South African variant and not directly to the Indian variant.

Since the concerning Covid-19 variant, known as B.1.617.2, was first identified in India, it has ravaged that country and spread to at least 26 nations out of the 53 in the World Health Organization's (WHO) European Region, the organization said.

The WHO's regional director said on Thursday Covid-19 vaccines being deployed in Europe, including the Pfizer/BioNTech shot, appear able to protect against circulating virus variants that have caused concern because they are more easily transmitted.

Sahin was speaking with Turkish Health Minister Fehrettin Koca, who separately said the country recorded less than 10,000 daily new coronavirus cases for the first time since March 1.

Turkey, which briefly was second globally last month in new infections, is using the Pfizer/BioNTech vaccine as well as China's Sinovac Biotech shot in its vaccination program.

Top News

BionTech Covid-19 Vaccine / Covid-19 Indian variant

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • What needs to be done now?
    What needs to be done now?
  • Illustration: TBS
    Dhaka’s kerb market money exchangers losing out on customers
  • A woman walks past the International Monetary Fund (IMF) logo at its headquarters in Washington, US, 10 May 12018. Photo: REUTERS
    IMF urges Asia to be mindful of spillover risks from tightening

MOST VIEWED

  • Ryu Yong Chol, an official at North Korea's state emergency epidemic prevention headquarters, speaks during a daily coronavirus program on state-run television KRT, in this still image obtained from KRT footage released on May 20, 2022. REUTERS TV/KRT via REUTERS
    North Korea's Dr Fauci? Health official emerges as face of Covid campaign
  • Workers in protective suit spray disinfectant at a community, during the lockdown to curb the spread of the coronavirus disease (COVID-19) in Shanghai, China, April 5, 2022. REUTERS/Aly Song
    Shanghai detects new infections after five days of 'zero Covid'
  • Volunteers carry out temperature screening during an anti-virus campaign in Pyongyang, North Korea in this image released by North Korea's Korean Central News Agency (KCNA) on March 4, 2020. KCNA via REUTERS/File Photo
    North Korea hails 'good results' on Covid as fever cases pass 2 million
  • Medical staff members check the temperature of people as they enter at Capital Airport, following an outbreak of Covid-19, in Beijing, China, 5 November, 2020. Photo: Reuters
    China relaxes some Covid test rules for US, other travellers
  • Representational image.
    China Junshi's potential Covid drug shows promise in small trial
  • A woman wearing protective mask walks at a sidewalk near business district in Jakarta, Indonesia March 2, 2020. REUTERS/Willy Kurniawan/Files
    Indonesia to drop outdoor mask mandate as Covid-19 infections drop

Related News

  • Pfizer/BioNTech Covid-19 vaccine shows 90.7% efficacy in trial in children
  • Pfizer/BioNTech Covid-19 vaccine effectiveness drops after 6 months, study shows
  • US FDA grants full approval to Pfizer-BioNTech Covid-19 vaccine
  • Pfizer, BioNtech submit data to FDA for Covid-19 vaccine booster authorisation
  • BioNTech says vaccine repeats beat devising new one for now

Features

Beef Kunafa: A treat for beef and cheese lovers

Beef Kunafa: A treat for beef and cheese lovers

38m | Food
A green economic transition must not affect the wellbeing of the over 4 million RMG workers. Picture: MumitM/TBS

Just Transition in an unjust world

1h | Analysis
Two paddle steamers (orange coloured) and two new steamers are docked at Badamtoli Rocket Ghat on the bank of the River Buriganga in Old Dhaka. The photo was taken recently. Photo: Mumit M

The last water rockets

2h | Features
Illustration: TBS

Dhaka’s kerb market money exchangers losing out on customers

2h | Panorama

More Videos from TBS

Gazipur restaurant that serves 150 food items

Gazipur restaurant that serves 150 food items

33m | Videos
How to prepare for a job

How to prepare for a job

1h | Videos
Putin's strategies to face Nato

Putin's strategies to face Nato

13h | Videos
How many countries have nuclear weapons and how many are there?

How many countries have nuclear weapons and how many are there?

13h | Videos

Most Read

1
Tk100 for bike, Tk2,400 for bus to cross Padma Bridge
Bangladesh

Tk100 for bike, Tk2,400 for bus to cross Padma Bridge

2
Representative Photo: Pixabay.
Bangladesh

Microplastics found in 5 local sugar brands

3
Mushfiq Mobarak. Photo: Noor-A-Alam
Panorama

Meet the Yale professor who anchors his research in Bangladesh and scales up interventions globally

4
A packet of US five-dollar bills is inspected at the Bureau of Engraving and Printing in Washington March 26, 2015. REUTERS/Gary Cameron
Banking

Dollar hits Tk100 mark in open market

5
The story of Bangladesh becoming a major bicycle exporter
Industry

The story of Bangladesh becoming a major bicycle exporter

6
PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire
Crime

PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab